Strategic siRNA Screening Approaches to Target Cancer at the Cancer Research UK Beatson Institute
Emma J. ShanksAffiliation:
Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK.
AbstractThe RNAi Screening Facility at the Cancer Research UK Beatson Institute combines siRNA genome-wide screening with drug screening coupled with High Content Imaging and fluorescence-based phenotypic assays to target multiple types of cancer. Here, we describe the infrastructure of the Facility and the approaches we utilise. We also share our experiences in running such a facility and developing and executing screening campaigns, with particular regard to high content multiparametric analysis, data management and statistical analysis.
Cancer, high content analysis, phenotypic screening, RNAi screening, statistical analysis.
Download Free Order Reprints Order Eprints Rights and Permissions